Actos

The pharmaceutical drug Actos is a Type-2 diabetes medication found to be linked to the onset of bladder cancer.  The generic, pioglitazone, is sold under other names such as Glustin, Actosplus, Deutact, Oseni.

In June 2011 the U.S. Food and Drug Administration warned that there is a 40% increase in bladder cancer risk in people using the drug for longer than one year.  In some European countries, Actos has been banned.

If you were taking Actos and have developed health problems due to the drug, please contact us at central@globaljusticenetwork.com.